Regeneron's REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
"Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severerespiratory complications of COVID-19"
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19
Treatment of COVID-19 patients with hydroxychloroquine or chloroquine: A retrospective analysis.
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial.
Safety and Effectiveness of High-Dose Vitamin C in Patients with COVID-19; A Randomized Controlled open-label Clinical Trial.
Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study.
The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis.
Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double blind dose response study in Lagos.
Lack of Association of Baseline 25-Hydroxyvitamin D Levels and Cholecalciferol Treatment With Disease Severity and Mortality in Indian Patients Hospitalized for Covid-19.
Prophylactic use of Hydroxychloroquine among Physicians working in Pandemic Hospitals.
Credible learning of hydroxychloroquine and dexamethasone effects on COVID-19 mortality outside of randomized trials.
Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients.
Efficacy and Safety of Indomethacin in Covid -19 patients.
A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152.
Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States.
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans.
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial.
Galectin antagonist use in mild cases of SARS-CoV-2 cases; pilot feasibility randomised, open label, controlled trial.
A first-in-human evaluation of the safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19 in healthy adults; a phase 1, randomised, double-blind, placebo-controlled trial.
Detailed disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic: An exploratory analysis.
Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
A two-arm, randomized, controlled, multi-centric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19.
Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial.
Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 Patients.
Clinical Efficacy of Eucaloric Ketogenic Nutrition in the COVID-19 Cytokine Storm: a Retrospective Analysis of Mortality and ICU Admission.
The efficacy and safety of hydroxychloroquine in COVID19 patients: a multicenter national retrospective cohort.
Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial.
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naïve and Experienced COVID-19 Patients.
Prevention of severe COVID-19 in the elderly by early high-titer plasma.
Effectiveness of remdesivir with and without dexamethasone in hospitalized patients with COVID-19.
5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men.
Effect of Vitamin D3 Supplementation vs Placebo on Hospital Length of Stay in 2 Patients with Severe COVID-19: A Multicenter, Double-blind, Randomized 3 Controlled Trial.
Peginterferon-lambda for the treatment of COVID-19 in outpatients.
Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic.
Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic.
Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients.
Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection.
Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency.
Evaluating the Efficacy of Tocilizumab in Moderate to Severe COVID-19 with Progressive Illness despite Steroids: Identifying the Optimal Timing of its Administration in C3G study.
Reducing the use of empiric antibiotic therapy in patients on admission to the hospital with COVID-19.
"Repurposing of drugs for Covid-19: asystematic review and meta-analysis"
A systematic review of Anakinra, Sarilumab, Siltuximab with meta-analysis of Tocilizumab for Covid-19.
Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study
Evidence favoring the efficacy of convalescent plasma for COVID-19 therapy
Early Tocilizumab Dosing is Associated with Improved Survival In Critically Ill Patients Infected With SARS-CoV-2
Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: A matched case-control study
The use of compassionate Ivermectin in the management of symptomatic outpatients and hospitalized patients with clinical diagnosis of COVID-19 at the Medical Center Bournigal and the Medical Center Punta Cana, Rescue Group, Dominican Republic, from may 1 to august 10, 2020
Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial.
Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study
Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients
The Role of Vitamin D in The Age of COVID-19: A Systematic Review and Meta-Analysis
Equine hyperimmune globulin raised against the SARS-CoV-2 spike glycoprotein has extremely high neutralizing titers
Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19
Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Pilot Trial of High-dose vitamin C in critically ill COVID-19 patients
Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia
Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management
Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq
Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial
Clinical Course and Outcomes of coronavirus disease 2019 (COVID-19) in Rheumatic Disease Patients on Immunosuppression: A case Cohort Study at a Single Center with a Significantly Diverse Population
Dexamethasone use and Mortality in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study
Intravenous Mesenchymal Stem Cells in Extracorporeal Oxygenation Patients with Severe COVID-19 Acute Respiratory Distress Syndrome
Treatment with human umbilical cord-derived mesenchymal stem cells for COVID-19 patients with lung damage: a randomised, double-blind, placebo-controlled phase 2 trial
Efficacy and Safety of Arbidol in Treatment of Patients with COVID-19 Infection: A Randomized Clinical Trial
Large population study identifies drugs associated with reduced COVID-19 severity
Tocilizumab is associated with reduction in inflammation and improvement in P/F ratio in critically sick COVID19 patients
Pharmacological treatment for patients with coronavirus disease 2019: systematic review of randomized controlled trials
Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results
Melatonin is significantly associated with survival of intubated COVID-19 patients
A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
CLINICAL COURSE AND OUTCOME OF COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME: DATA FROM A NATIONAL REPOSITORY
Tocilizumab in Treatment of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis of Cohort Studies
Enoxaparin is associated with lower rates of thrombosis, kidney injury, and mortality than Unfractionated Heparin in hospitalized COVID patients
Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in COVID-19
Effect of convalescent plasma on mortality in patients with COVID-19 pneumonia
Montelukast in Hospitalized Patients Diagnosed with COVID-19
COVID-19: Ivermectin prophylaxis in adult contacts. Report on First Cases of Prophylaxis for Healthcare Personnel and PostExposure Prophylaxis
Renin Angiotensin System Inhibition and Susceptibility and Outcomes from COVID-19: A Systematic Review and Meta-analysis of 69,200 COVID-19 Patients
Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving the Partial Pressure of Arterial Oxygen and Fraction of Inspired Oxygen Ratio among COVID-19
An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial)
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
Anakinra After Corticosteroid and/or Tocilizumab Treatment in Patients with Severe COVID-19 Pneumonia and Moderate Hyperinflammation. A Retrospective Cohort Study
Systematic review and patient-level meta-analysis of SARS-CoV-2 viral dynamics to model response to antiviral therapies
Convalescent plasma treatment of severe COVID-19: A matched control study
Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19
Hydroxychloroquine as Post-Exposure Prophylaxis for Covid-19: Why simple data analysis can lead to the wrong conclusions from well-designed studies
Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers - a Retrospective cohort
Pathogenesis-based pre-exposure prophylaxis associated with low risk of SARS-CoV-2 infection in healthcare workers at a designated Covid-19 hospital
A Randomized Controlled Study Of Favipiravir Vs Hydroxychloroquine In COVID-19 Management: What Have We Learned So Far?
Corticosteroid pulses for hospitalized patients with COVID-19: Effects on mortality and in-hospital stay
Comprehensive Systematic Review to Identify putative COVID-19 Treatments: Roles for Immunomodulator and Antiviral Treatments
Impact of tocilizumab administration on mortality in severe COVID-19
Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial
Evaluation of the Efficacy of Methylprednisolone Pulse Therapy in Treatment of Covid-19 Adult Patients with Severe Respiratory Failure: Randomized
A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients
Engineered interferon alpha effectively improves clinical outcomes of COVID-19 patients
Clearing the fog: Is HCQ effective in reducing COVID-19 progression: A randomized controlled trial
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis
Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Efficacy of Famotidine for COVID-19: A Systematic Review and Meta-analysis
The Impact of Colchicine on The COVID-19 Patients: A Clinical Trial Study
Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
"High-dose vitamin C infusion for the treatment ofcritically ill COVID-19"
Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
Pentoxifylline and Covid-19: A Systematic Review
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: A randomised placebo-controlled double-blind clinical trial
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: initial results of a double-blind, placebo-controlled randomized clinical trial
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials.
Clinical Outcomes and Plasma Concentrations 1 of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
Effect of Arbidol on COVID-19: A Randomized Controlled Trial
Combination of Tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: A spanish, multicenter, cohorty study
Safety and Efficacy of Antiviral Drugs for the Treatment of Patients with SARS-CoV-2 Infection: A Systematic Review and Meta-analyses
The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in Baghdad, Iraq
Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19
Early viral clearance among COVID-19 patients when gargling with Povidone-iodine and essential oils – a clinical trial
The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study
Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort study
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial.
Role of Drugs used for chronic disease management on Susceptibility and Severity of COVID-19: A Large Case-Control Study
Characterization and Phase 1 Trial of a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
The link between vitamin D deficiency and Covid-19 in a large population
"Beneficial and Harmful Outcomes of Tocilizumab in Severe COVID-19:A Systematic Review and Meta-Analysis"
Addition of Tocilizumab to the standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)
Convalescent plasma as potential therapy for severe COVID-19 pneumonia
Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis
COVID-19 mortality risk factors in older people in a long-term care center
Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization: A Systematic Review
Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients
Hydroxicloroquine for pre-exposure prophylaxis for SARS-CoV-2
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three Month Experience
Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
A COVID-19 vaccine candidate 1 using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein
Evaluation of the current therapeutic approaches for COVID-19: a meta-analysis
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2
Pleiotropic effect of Lactoferrin in the prevention and treatment of COVID-19 infection: randomized clinical trial, in vitro and in silico preliminary evidences
Anti-C5a antibody (IFX-1) treatment of severe Covid-19: an exploratory phase 2 randomized controlled trial
OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?
Outcomes of Persons With COVID-19 in Hospitals With and Without Standard Treatment With (Hydroxy)chloroquine
Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19 A proof-of-concept study
Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin - A real world experience
Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report
Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial
Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis
Effectiveness of booster BCG vaccination in preventing Covid-19 infection
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial
Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette–Guérin vaccine: A case study of beta cells regeneration by serendipity
First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine
Therapeutic effectiveness of interferon alpha 2b treatment for COVID-19 patient recovery
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19
Prophylaxis with tetracyclines in ARDS: Potential therapy for COVID-19-induced ARDS?
Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA
Efficacy and tolerability of bevacizumab 2 in patients with severe Covid -19
Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19
Intravenous immunoglobulin (IVIG) significantly reduces respiratory morbidity in COVID-19 pneumonia: a prospective randomized trial
A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease
Corticosteroid Use in Severely Hypoxemic COVID-19 Patients: An Observational Cohort Analysis of Dosing Patterns and Outcomes in the Early Phase of the Pandemic
A meta-review of systematic reviews and an updated metaanalysis on the efficacy of chloroquine and hydroxychloroquine in treating COVID19 infection
Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002)
Association between NSAIDs use and adverse clinical outcomes among adults hospitalised with COVID-19 in South Korea: A nationwide study
Effectiveness and Safety of Chloroquine or hydroxychloroquine as a mono-therapy or in combination with Azithromycin in the treatment of COVID-19 patients: Systematic Review and Meta-Analysis
COVID-19 Severity in Europe and the USA: Could the Seasonal Influenza Vaccination Play a Role?
Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine
Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US
ISARIC Clinical Data Report 8 June 2020
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study
Second Week Methyl-Prednisolone Pulses Improve Prognosis In Patients With Severe Coronavirus Disease 2019 Pneumonia: An Observational Comparative Study Using Routine Care Data.
Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid
Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort Study
Do low TB prevalence or lack of BCG Vaccination Contribute to Emergence Multisystem Inflammatory Syndrome?
Effects of Tocilizumab in Critically Ill Patients With COVID-19: A Quasi-Experimental Study
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Treatment response to hydroxychloroquine and antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea
A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
Addition of Tocilizumab to standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
Association between angiotensin-converting enzyme inhibitors and angiotensin II 2 receptor blockers use and the risk of infection and clinical outcome of COVID-19: a 3 comprehensive systematic review and meta-analysis
Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
Strong Correlation Between Prevalence of Severe Vitamin D Deficiency and Population Mortality Rate from COVID-19 in Europe
Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities
Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France
Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studies
Efficacy and Safety of Remdesivir for COVID-19 Treatment: An Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Real-world Experience with Favipiravir for Treatment of COVID-19 in Thailand: Results from a Multicenter Observational Study
Hydroxychloroquine has no effect on SARS-CoV-2 load in nasopharynx of patients with mild form of COVID-19
Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study
Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19
Convalescent Plasma for COVID-19. A randomized clinical trial
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection
ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19
Influenza Vaccination and COVID19 Mortality in the USA
The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study
Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study
Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
Observational Study of Metformin and Risk of Mortality in Persons Hospitalized with Covid-19
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
Pre exposure Hydroxychloroquine Prophylaxis for COVID-19 in healthcare workers: a retrospective cohort
Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population.
Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab – A Case- Controlled Study.
Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study.
Clozapine treatment and risk of COVID-19.
Effect of hydroxychloroquine on SARS-CoV-2 viral load in patients with COVID-19.
Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis.
GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia.
Remdesivir Efficacy in Coronavirus Disease 2019 (COVID-19): A Systematic Review.
Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late.
Explore the Possible Impact of BCG Vaccination Policy on the Morbidity, Mortality, and Recovery Rates due to COVID-19 Infection.
Hydroxychloroquine-Induced Stevens-Johnson Syndrome in COVID-19: A rare Case Report.
A 78-year Old Urothelial Cancer Patient with Faster Recovery from COVID-19: Potential Benefit from Adjuvant Active Immunotherapy.
Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review.
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study.
Therapeutic effectiveness of interferon-alpha 2b against COVID-19: the Cuban experience.
Effects of Tocilizumab on Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study.
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs tested positive for SARS-CoV-2: a danish nationwide cohort study.
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
Association of Vitamin D Deficiency and Treatment with COVID-19 Incidence.
Tobaiqy M, Helmi N, Majrashi M, Majrashi M, Al-Dahery S, Mujallad A. COVID-19 therapeutics outcome: systematic review and data analysis. Research Square. 2020. Disponível em: https://doi.org/10.21203/rs.3.rs-33391/v1
Assessment of Hydroxychloroquine and Chloroquine Safety Profiles – A Systematic Review and Meta-Analysis.
Association of Renin-Angiotensin-Aldosterone System Inhibition with Risk of COVID-19, Inflammation Level, Severity and Death in Patients With COVID-19: A Rapid Systematic Review and Meta-Analysis.
Association Between ACEIs or ARBs Use and Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-analysis.
A shred of evidence that BCG vaccine may protect against COVID-19: Comparing cohorts in Spain and Italy.
Tocilizumab is associated with reduced risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
Association of Bacille Calmette-Guérin (BCG), Adult Pneumococcal and Adult Seasonal Influenza Vaccines with Covid-19 Adjusted Mortality Rates in Level 4 European countries.
Ozone therapy for patients with SARS-COV-2 pneumonia: a single-center prospective cohort study.
Efficacy and Safety of Leflunomide for Refractory COVID-19: An Open-label Controlled Study.
A SYSTEMATIC ANALYSIS OF THE TIME COURSE TO DEVELOP TREATMENTS FOR COVID-19.
Rapid systematic review on clinical evidence of chloroquine and hydroxychloroquine in COVID-19: critical assessment and recommendation for future clinical trials.
"Plasma concentration and safety of lopinavir/ritonavir in patients with Covid-19: a 2 retrospective cohort study"
Impact of glucocorticoid treatment in Sars-CoV-2 infection mortality: a retrospective controlled Cohort Study
Renin-angiotensin-aldosterone system inhibitors and mortality in patients with hypertension hospitalized for COVID19: systematic review &meta-analysis
Effect of various treatment modalities on the novel coronavirus (nCOV-2019) infection in humans: a systematic review & meta-analysis
Use of inhibitors of the renin angiotensin system and COVID-19 prognosis: a systematic review and meta-analysis
Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study
Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis
A Systematic Review and Meta-analysis of Therapeutic options against SARS-CoV-2
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically 2 ventilated COVID-19 patients: A case series
Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
Off-Label Real World Experience Using Tocilizumab for Patients Hospitalized with COVID-19 Disease in a Regional Community Health System: A Case-Control Study
Sarilumab use in severe SARS-CoV-2 pneumonia
Hydroxychloroquine in COVID-19: A systematic review and meta-analysis
Improved survival outcome in SARs-CoV-2 (COVID-19) Acute Respiratory Distress Syndrome patients with Tocilizumab administration
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust
Systematic Review and Meta-analysis of the Effectiveness and Safety of Hydroxychloroquine in COVID-19
Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a framework for rapid decision-making
Steroid-responsive encephalitis in Covid-19 disease
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
Does BCG protect against SARS-CoV-2 infection ?: elements of proof
COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective?
Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
Ocular toxicity and Hydroxychloroquine: A Rapid Meta-Analysis
Lopinavir-ritonavir alone or combined with arbidol in the treatment of 73 hospitalized patients with COVID-19: a pilot retrospective study
The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): A meta-analysis
A systematic review of Anakinra, Tocilizumab, Sarilumab and Siltuximab for coronavirus-related infections
Intravenous Immunoglobulin of COVID-19 Effectiveness of Intravenous Immunoglobulin for Children with Severe COVID-19: A Rapid Review
The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysis
Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases
A Computational Approach to Design Potential siRNA Molecules as a Prospective Tool for Silencing Nucleocapsid Phosphoprotein and Surface Glycoprotein Gene of SARS-CoV-2
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Heparin therapy improving hypoxia in COVID-19 patients - a case series
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019（COVID-19).
Design an efficient multi-epitope peptide vaccine candidate against SARS-CoV-2: An in silico analysis
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19
Rapid development of an inactivated vaccine for SARS-CoV-2
Potential Effectiveness and Safety of Antiviral Agents in Children with Coronavirus Disease 2019: A Rapid Review and Meta-Analysis
Steroid-responsive severe encephalopathy in SARS-CoV-2 infection
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
The FDA-approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A multicenter retrospective cohort study
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial
Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens
The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro
Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression
Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis
Interferon-α2b treatment for COVID-19
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical
COVID-19 infection during pregnancy: A systematic review to summarize possible symptoms, treatments, and pregnancy outcomes
BCG protects against COVID-19? A word of caution
Convalescent Plasma to Treat COVID-19: Chinese Strategy and Experiences
Human monoclonal antibodies block the binding of SARS CoV 2 spike protein
Hydroxychloroquine (HCQ): an observational cohort study in primary and secondary prevention of pneumonia in an at-risk population
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)
Therapeutic Application of Chloroquine and Hydroxychloroquine in Clinical Trials for COVID-19: A systematic review
Differential COVID-19-attributable mortality and BCG vaccine use in countries
Association of BCG vaccination policy with prevalence and mortality of COVID-19
Targeting the catecholamine-cytokine axis to prevent SARS-CoV-2 cytokine storm syndrome
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Lack of Antiviral Activity of Darunavir against SARS-CoV-2
Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking
Kamal MA, Helmi N. Therapeutic Management of COVID-19 Patients: A systematic review
Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin
Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis
Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series
DEVELOPMENT OF A HYPERIMMUNE EQUINE SERUM THERAPY FOR COVID-19 IN ARGENTINA
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations
A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine’s Prophylactic Effect Against Infection With SARS-CoV-2
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
A Thermostable mRNA Vaccine against COVID-19
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
A human monoclonal antibody blocking SARS-CoV-2 infection
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MSE analysis
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Peptide-like and small-molecule inhibitors against Covid-19
Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Why are lopinavir and ritonavir effective against the newly emerged Coronavirus 2019?: Atomistic insights into the inhibitory mechanisms
Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Via Integrated Computational Approach
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Targeting Novel Coronavirus 2019: A Systematic Drug Repurposing Approach to Identify Promising Inhibitors Against 3C-like Proteinase and 2'-O-Ribose Methyltransferase
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
A vaccine for SARS-CoV-2: goals and promises
Does vitamin D status impact mortality from SARS-CoV-2 infection?
Covid-19 treatment update: follow the scientific evidence
Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19
Standing out from the crowd in treating COVID-19
G6PD and chloroquine: selecting the treatment against SARS-CoV-2?
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need
COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence.
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
DRAFT landscape of COVID-19 candidate vaccines – 03 November 2020
HCQ is effective for COVID-19 when used early: analysis of 118 studies
DRAFT landscape of COVID-19 candidate vaccines – 19 October 2020
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
DRAFT landscape of COVID-19 candidate vaccines – 02 October 2020
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
DRAFT landscape of COVID-19 candidate vaccines – 28 September 2020
DRAFT landscape of COVID-19 candidate vaccines – 21 September 2020
DRAFT landscape of COVID-19 candidate vaccines – 23 September 2020
DRAFT landscape of COVID-19 candidate vaccines – 17 September 2020
DRAFT landscape of COVID-19 candidate vaccines – 9 September 2020
DRAFT landscape of COVID-19 candidate vaccines – 8 September 2020
DRAFT landscape of COVID-19 candidate vaccines – 28 August 2020
DRAFT landscape of COVID-19 candidate vaccines – 25 August 2020
Tocilizumab en infección por COVID-19
Remdesivir en pacientes con COVID-19
DRAFT landscape of COVID-19 candidate vaccines – 20 August 2020
INTERFERON PARA PROFILAXIA E TRATAMENTO DE COVID-19. Revisão sistemática rápida
Uso de dexametasona en pacientes internados con COVID-19
Lopinavir-Ritonavir para infecção por SARS-CoV-2 (Covid-19). Revisão sistemática rápida.
Hidroxicloroquina e cloroquina para Covid-19. Revisão sistemática de ensaios clínicos randomizados
REPORTE BREVE Nº 30 USO DE ANAKINRA PARA EL TRATAMIENTO DE PACIENTES CON EL DIAGNOSTICO DE COVID-19, 2020.  SEGURO SOCIAL DE SALUD - ESSALUD INSTITUTO DE EVALUACION DE TECNOLOGIAS EN SALUD E INVESTIGACIÓN
Uso de dexametasona en pacientes internados con COVID-19 - Informe de Evaluación de Tecnología Sanitaria
DRAFT landscape of COVID-19 candidate vaccines – 10 August 2020
Drug vignettes: Remdesivir
Drug vignettes: Interferons
DRAFT landscape of COVID-19 candidate vaccines – 31 July 2020
DRAFT landscape of COVID-19 candidate vaccines – 27 July 2020
DRAFT landscape of COVID-19 candidate vaccines – 21 July 2020
DRAFT landscape of COVID-19 candidate vaccines – 15 July 2020
DRAFT landscape of COVID-19 candidate vaccines – 13 July 2020
Eficácia da Ivermectina para o Tratamento da Covid-19. Revisão sistemática rápida
Emergence of institutional antithrombotic protocols for coronavirus 2019
DRAFT landscape of COVID-19 candidate vaccines – 06 July 2020
Associação hidroxicloroquina/ cloroquina e azitromicina para Covid-19
Tocilizumabe para infecção por SARS-CoV-2 (COVID-19) Revisão sistemática rápida
Corticoides para infecção por SARS-CoV-2 (Covid-19) Revisão sistemática rápida.
DRAFT landscape of COVID-19 candidate vaccines – 24 June 2020
DRAFT landscape of COVID-19 candidate vaccines – 22 June 2020.
DRAFT landscape of COVID-19 candidate vaccines – 18 June 2020.
Targeted Update: Safety and efficacy of hydroxychloroquine or chloroquine for treatment of COVID-19
Uso de plasma de pacientes recuperados no tratamento de COVID-19. Revisão sistemática rápida.
Heparina para Covid-19. Revisão sistemática rápida.
Eficácia, segurança e prognóstico associados ao uso de Inibidores da Enzima Conversora de Angiotensina (IECA) e Bloqueadores do Receptor de Angiotensina 2 (BRA) para COVID-19. Revisão sistemática rápida.
DRAFT landscape of COVID-19 candidate vaccines - 16 June 2020
DRAFT landscape of COVID-19 candidate vaccines - 9 June 2020
Nitazoxanida no tratamento de covid-19. Revisão sistemática rápida.
Tocilizumabe para infecção por SARS-CoV-2 (COVID-19) Revisão sistemática rápida.
Remdesivir para infecção por SARS-CoV-2 (COVID-19). Revisão sistemática.
Hidroxicloroquina e cloroquina para Covid-19. Revisão sistemática rápida
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews. Rapid Review, 8 May 2020
DRAFT landscape of COVID-19 candidate vaccines - 15 May 2020
Corticoides para infecção por SARS-CoV-2 (Covid-19) Revisão sistemática rápida
Associação hidroxicloroquina/cloroquina e azitromicina para Covid-19.
Uso de Tocilizumab para el tratamiento de pacientes con COVID-19. Reporte breve n° 01.
Uso de Oseltamivir para el tratamiento de pacientes con COVID-19. Reporte breve n° 01.
Uso de atazanavir para el tratamiento de pacientes con diagnóstico de COVID-19. Reporte breve n° 02.
Uso de AINES en pacientes con diagnóstico de COVID-19. Reporte breve n° 013.
Draft landscape of COVID 19 candidate vaccines - 11 May 2020
COVID-19 Informal consultation on the dose of chloroquine and hydroxychloroquine for the SOLIDARITY Clinical Trial
DRAFT landscape of COVID-19 candidate vaccines - 5 May 2020
What is the evidence for using macrolide antibiotics to treat COVID-19?
Drug vignettes: Tocilizumab
Heparinas para infecção por SARS-CoV-2 (COVID-19). Revisão sistemática rápida
"Remdesivir parainfecção por SARS-CoV-2 (COVID-19). Revisão sistemática"
Vitamin D: A rapid review of the evidence for treatment or prevention in COVID-19
A rapid review of the evidence for treatment or prevention in COVID-19
DRAFT landscape of COVID-19 candidate vaccines - 20 April 2020
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
DRAFT landscape of COVID-19 candidate vaccines - 23 April 2020
Nitazoxanida para tratamento de COVID-19: Revisão Sistemática Rápida
Atazanavir para COVID-19. Revisão sistemática rápida
Uso de plasma de pacientes recuperados no tratamento de COVID-19. Revisão sistemática rápida
Inibidores da janus associated kinases para COVID-19.
Antagonistas do receptor da endotelina para o tratamento de pacientes com COVID-19
Antagonistas do receptor da ivermectina para o tratamento de pacientes com COVID-19
DRAFT landscape of COVID-19 candidate vaccines – 4 April 2020
Remdesivir for severe covid-19: a clinical practice guideline
Guidelines for the pharmacological treatment of COVID-19. The task force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology
Interim Guidelines on Antiviral Therapy for COVID-19
Risk of metformin in type 2 diabetes patients with COVID-19: a preliminary retrospective report
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched case-control study
Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
Towards evidence-based Emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: Hydroxychloroquine in the treatment of COVID-19
"Use of Darunavir-Cobicistat as a Treatment Optionfor Critically Ill Patients with SARS-CoV-2 Infection"
A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19)
A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island
Corticosteroid Therapy in COVID-19 Disease
Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy
Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals? International Journal of Antimicrobial Agents
"Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19"
Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
Mortality of COVID-19 with preadmission metformin use in patients with diabetes: a meta-analysis
Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study
Efficacy of tocilizumab treatment in severely ill COVID-19 patients
"Argatroban for therapeutic anticoagulation for heparin resistanceassociated with Covid-19 infection"
“Toxic erythema” and eosinophilia associated to tocilizumab therapy in a COVID-19 patient
Drug-induced vasculitis in a patient with COVID-19
Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
IL-6 blockade treatment for severe COVID-19 in two patients with multiple myeloma
A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials.
L’hydroxy-chloroquine pour traiter les patients infectes du ´COVID-19: quelques lec¸ons d’an-thropologie medicale et d’histoire de la m ´ edecine
Amiodarone in the COVID‑19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
An Inactivated Virus Candidate Vaccine to Prevent COVID-19
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
The use of dexamethasone in the treatment of COVID-19
Anakinra in COVID-19: important considerations for clinical trials
Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy
A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals
Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?
Vitamin D for COVID-19: a case to answer?
Practical considerations in prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19
Hydroxychloroquine and Azithromycin as Treatments for COVID-19
Rituximab: a safe therapeutic option during the COVID-19 pandemic? Journal of Dermatological Treatment. 22 de julho de 2020;1–3. DOI: 10
Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
The effect of BCG vaccine in the era of COVID-19 pandemic
How should we treat pregnant women infected with SARS-CoV-2?
Anakinra for patients with COVID-19
Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making
Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19?
Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
New international guidance on quality, safety and efﬁcacy of DNA vaccines
COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution
Rapid advice guidelines for management of children with COVID-19
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
Ivermectin: potential candidate for the treatment of Covid 19
BCG is a Good Immunotherapeutic Agent for Viral and Autoimmune Diseases: Is it a New Weapon against Coronavirus (COVID-19)?
Does zinc improve symptoms of viral upper respiratory tract infection? Evidence-Based Pract
Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
Ensuring Uptake of Vaccines against SARS-CoV-2
Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?
Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy
Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic.
COVID-19 in patients with rheumatological diseases treated with anti-TNF.
Amplifying RNA Vaccine Development.
Hydroxychloroquine for covid-19: the end of the line?
Monoclonal Antibodies for Prevention and Treatment of COVID-19.
Convalescent Plasma and COVID-19.
COVID-19 vaccines for all?
Can existing live vaccines prevent COVID-19?
COVID-19 vaccine development pipeline gears up.
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.
Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed
Dermatologic manifestations of hydroxychloroquine therapy: a closer look at the nails
Precision Medicine in COVID-19: IL-1β a Potential Target
SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
Drug vignettes: Azithromycin
A recommendation for the use of chloroquine, hydroxychloroquine, primaquine or tafenoquine for prophylaxis againts the 2019 novel coronavirus (COVD-19) with note to the ophthalmic considerations
Covid‐19 and drug therapy, what we learned
The FDA has authorised remdesivir for use in COVID-19 patients: but there’s no good evidence it reduces mortality
Metformin in COVID-19: A possible role beyond diabetes
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
Emergency Use Authorization of remdesivir by the US Food and Drug Administration
Can melatonin reduce the severity of COVID-19 pandemic?
Headache medication and the COVID-19 pandemic
COVID-19 therapeutic options for patients with kidney disease
The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
Angiotensin Receptor Blockers and 2019-nCoV
Challenges of Convalescent Plasma Therapy on COVID-19
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and reninangiotensin system blockers in SARS-CoV-2 infections
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action
Inaccurate conclusions by Tang and colleagues
Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine
Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19
Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis
The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
EMA advice on renin-angiotensin system medicines during covid-19 pandemic
"Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology"
"Reply to ""Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"
Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Potential of Heparin and Nafamostat Combination Therapy for COVID-19
Amiodarone as a possible therapy for coronavirus infection
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view
Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies
Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials
Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19
Why tocilizumab could be an efective treatment for severe COVID-19?
Coronavirus Vaccines: Light at the End of the Tunnel
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use
Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?
Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
Pharmaceutical are of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID-19)
Drug Evaluation during the Covid-19 Pandemic
Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment?
Chloroquine and hydroxychloroquine in covid-19.
Type 1 interferons as a potential treatment against COVID-19
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
Therapeutic Potential for Tetracyclines in the Treatment of COVID-19
Considerations for statin therapy in patients with COVID-19
Regulators split on antimalarials for COVID-19
SARS-CoV-2 Vaccines: Status Report
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
Comunicado a la opinión pública uso de Hidroxicloroquina / Public opinion on the use of Hydroxychloroquine
Macrolide treatment for COVID-19: Will this be the way forward?
The versatile heparin in COVID-19. Journal of thrombosis and haemostasis
Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial.
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2.
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study.
Corticosteroid treatment has no efect on hospital mortality in COVID‐19 patients.
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine.
The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.
Efficacy Evaluation of Intravenous Immunoglobulin in Non-severe Patients with COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study.
Impact of oral anticoagulation on clinical outcomes of COVID‐19: a nationwide cohort study of hospitalized patients in Germany.
Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization.
Matched cohort study on the efficacy of tocilizumab in patients with COVID-19.
Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma.
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
Clinical outcome, viral response and safety profile of chloroquine in COVID-19 patients—initial experience.
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.
Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study.
The Role of Vitamin C as Adjuvant Therapy in COVID-19.
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients.
Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19.
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.
Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis.
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study.
Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France.
Efectividad de los glucocorticoides en pacientes hospitalizados por neumonía grave por SARS-CoV-2.
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy.
Low vitamin D status is associated with coronavirus disease 2019 outcomes: A systematic review and meta-analysis
Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies.
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.
Comparing ICU Admission Rates of Mild/Moderate COVID-19 Patients Treated with Hydroxychloroquine, Favipiravir, and Hydroxychloroquine plus Favipiravir.
Tocilizumab in the Management of COVID-19: A Preliminary Report.
No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Safety and Efficacy of Convalescent Plasma for Severe COVID‐19: Interim Report of a Multicenter Phase II Study from Saudi Arabia.
Effects of Tocilizumab in COVID-19 patients: a cohort study.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting Real-World Data from a Multicenter Observational Study Targeting Inflammatory & Infectious Dermatoses.
Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia.
Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai
Early Clinical Outcomes with Tocilizumab for Severe Covid-19: A Two-Center Retrospective Study.
QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases.
Corticosteroid therapy in critically ill patients with COVID‑19: a multicenter, retrospective study.
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis.
A systematic review and meta‑analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID‑19 treatment
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
Convalescent plasma may be a possible treatment for COVID-19: A systematic review.
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
Tocilizumab in the Treatment of Critical COVID-19 Pneumonia: A Retrospective Cohort Study of Mechanically Ventilated Patients.
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study.
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.
Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: A systematic review with meta-analysis.
Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.
Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: A retrospective observational study of 75 fatal cases.
Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel.
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection. A Randomized Trial.
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.
Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study.
A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study.
Ivermectin use associated with reduced duration of COVID-19 febrile illness in a community setting.
Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study.
COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome.
Blockage of interleukin‑1β with canakinumab in patients ith Covid‑19.
Corticosteroid use in COVID‑19 patients: a systematic review and meta‑analysis on clinical outcomes.
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824,650 Patients with Hypertension from a US integrated Healthcare System.
Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection.
Incidencia de la COVID-19 en pacientes en tratamiento crónico con hidroxicloroquina
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil.
Corticosteroid therapy is associated with improved outcome in critically ill COVID-19 patients with hyperinflammatory phenotype.
Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients.
Sars-Cov-2 Associated Coagulopathy and Thromboembolism Prophylaxis in Children: a Single Centre Observational Study.
Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study.
The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis.
Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients.
High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study
Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systemic Review of Clinical Trials.
First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia.
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
Corticosteroids in patients hospitalised for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
Association between seasonal flu vaccination and COVID-19 among healthcare workers.
Anakinra treatment in critically ill COVID‑19 patients: a prospective cohort study.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Repurposed Tocilizumab in Patients with Severe COVID-19.
Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A meta-Analysis of Randomized Clinical Trials.
Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: prospective, non-randomized trial.
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis.
The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019.
Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID‐19.
Severe COVID-19 pneumonia in Piacenza, Italy – a cohort study of the first pandemic wave.
Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19.
COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study.
Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study.
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.
Low-dose Whole-lung Irradiation for COVID-19 Pneumonia: Final Results of a Pilot Study.
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid‑19.
Increasing Age, the Existence of Comorbidities, and Corticosteroid Treatment in Combination With Antiviral Therapy Prolongs the Recovery of SARS-COV-2-Infected Patients, Measured as the Conversion From Positive to Negative rtPCR: A 239 Patients’ Retrospective Study.
Hydroxychloroquine/Azithromycin treatment, QT interval and ventricular arrhythmias in hospitalized patients with COVID‐19.
Adjunctive favipiravir for severe COVID-19: a retrospective observational study of the first 41 patients in Thailand.
An open-label, randomized trial of the combination of IFN-k plus TFF2 with standard care in the treatment of patients with moderate COVID-19.
Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease. A pilot study.
A systematic review of corticosteroid treatment for noncritically ill patients with COVID‑19.
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
Synergistic Effect of Quercetin and Vitamin C Against COVID-19: Is A Possible Guard for Front liners?
Hydroxychloroquine lung pharmacokinetics in critically ill patients infected with COVID-19.
A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
INFLUENCE OF TOCILIZUMAB ON THE OUTCOME OF PATIENTS WITH COVID-19. RETROSPECTIVE OBSERVATIONAL STUDY.
Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users.
A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
Efficacy of Remdesivir in Covid-19 Patients; Multicenter Study in Lahore.
Association between renin-angiotensin-aldosterone system inhibitor use and covid-19 hospitalization and death: a 1,4 million patient nation-wide registry analysis.
Systematic review on current antiviral therapy in COVID-19 pandemic.
Assessment of schistosomiasis endemicity and preventive treatment on coronavirus disease 2019 outcomes in Africa.
A COVID-19 Prophylaxis? Lower incidence associated with prophylactic administration of Ivermectin.
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications.
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.
Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.
Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease 1 and Implications for Clinical Trial Methodologies.
Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial.
Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19.
A Case–Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers.
Predictors of Mortality and Effect of Drug Therapies in Mechanically Ventilated Patients With Coronavirus Disease 2019: A Multicenter Cohort Study.
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
Tocilizumab administration is associated with reduction in biomarkers of coronavirus disease 2019 (COVID-19) infection.
Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
The effectiveness of early anticoagulant treatment in Covid-19 patients.
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease.
Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality.
Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019.
Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study.
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey.
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
Evidence for treatment with estradiol for women with SARS-CoV-2 infection.
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort.
Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.
Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A Natural Clinical Trial.
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
Therapeutic potential of ivermectin as add-on treatment in COVID 19: A systematic review and meta-analysis.
A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019.
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality
linical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.
The effects of favipiravir on hematological parameters of covıd-19 patients.
The effect of IL-6 inhibitors on mortality among hospitalized COVID-19 patients: a multicenter study.
Renin–angiotensin system inhibitors and mortality in patients with COVID‐19.
High-Dose Methylprednisolone in Nonintubated Patients with Severe COVID-19 Pneumonia.
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19.
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
Adverse impact of renin–angiotensin system blockade on the clinical course in hospitalized patients with severe COVID‐19: a retrospective cohort study.
"Comparison of Infection Risks and Clinical Outcomes in Patients with and without SARS-CoV-2 Lung Infection under Renin-Angiotensin-Aldosterone-System Blockade - Systematic Review and Meta-Analysis."
Non-steroidal anti-inflammatory drugs and susceptibility to COVID-19.
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital.
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study.
Risk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study.
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers.
Role of low-molecular weight heparin in hospitalized patients with SARS-CoV-2 pneumonia: a prospective observational study.
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study.
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Comparative analysis between the use of renin–angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults(COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19.
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study.
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years
Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial.
Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety.
Renin–angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review.
Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization.
Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19.
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.
A randomized clinical trial of the efficacy and safety of interferon β-1a in treatment of severe COVID-19.
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.
Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
Prophylactic or therapeutic doses of heparins for COVID‐19 infection? A retrospective study.
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study.
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
Utility of Ivermectin and Doxycycline combination for the treatment of SARS- CoV-2.
Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID‐19 registry.
Vitamin D Deficiency Is Inversely Associated with COVID-19 Incidence and Disease Severity in Chinese People.
Safety and efficacy of Artemisinin-Piperaquine for treatment of COVID-19: an open-label, non-randomized, and controlled trial.
Comparison between Prophylactic versus Therapeutic Doses of Low-Molecular-Weight Heparin in Severely Ill Coronavirus Disease 2019 Patients in Relation to Disease Progression and Outcome.
Letter: severe COVID‐19 infection and biologic therapies—a cohort study of 7808 patients in France.
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Control Study, Mayo Clinic Proceedings
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak.
Cloroquina y sus derivados en el manejo de la COVID-19: una revisión sistemática exploratoria
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
The efect of tocilizumab on cytokine release syndrome in COVID‐19 patients.
The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019.
Randomized Controlled Open Label Trial on the Use of Favipiravir Combined with Inhaled Interferon beta-1b in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia.
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial.
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series.
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
Corticosteroid therapy for coronavirus disease 2019‑related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study.
Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
Significantly decreased mortality in a large cohort of COVID-19 patients transfused early with convalescent plasma containing high titer anti-SARS-CoV-2 spike protein IgG.
Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 in health-care workers: A single-center experience.
Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries.
Therapeutic Plasma Exchange followed by Convalescent Plasma transfusion in critical COVID-19- an exploratory study.
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
Therapeutic Management of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Treatment Algorithm.
Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide.
The Cardiac Toxicity of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-regression Analysis.
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis.
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19.
QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry.
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.
Asociación entre el tratamiento esteroideo a dosis alta, la función respiratoria y el tiempo hasta el alta en pacientes con COVID-19: Estudio de cohortes.
The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature.
Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.
Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study.
Investigation of the frequency of COVID-19 in patients treated with intravesical BCG.
Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis.
Protection against SARS‐CoV‐2 by BCG vaccination is not supported by epidemiological analyses
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients.
Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes:  Prospective Cohort Study.
Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors.
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with COVID-19 (HAHPS): Results of a Randomized, Active Comparator Trial.
Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
Efficacy and safety of remdesivir in hospitalized Covid‐19 patients: Systematic review and meta‐analysis including network meta‐analysis
Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial
Blood ozonization in patients with mild to moderate COVID‑19 pneumonia: a single centre experience
Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study
Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19
Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19
Effect of Statin Therapy on SARS-CoV-2 Infection-Related Mortality in Hospitalized Patients
Statin Use and In-Hospital Mortality in Diabetics with COVID-19
Zinc and vitamin A deficiency predisposes to the need for intubation and ICU admission in patients with COVID-19. An observational study
Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
Impact of Corticosteroids in COVID-19 Outcomes: Systematic Review and Meta-Analysis
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome
A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of HealthWorkers
VITAMIN D TREATMENT IS ASSOCIATED WITH REDUCED RISK OF MORTALITY IN PATIENTS WITH COVID-19: A CROSS-SECTIONAL MULTI-CENTRE OBSERVATIONAL STUDY
Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis
OZONE AS ADJUVANT SUPPORT IN THE TREATMENT OF COVID-19: A PRELIMINARY REPORT OF PROBIOZOVID TRIAL
Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
Comparative Effectiveness of Lopinavir/Ritonavir-Based Regimens in COVID-19
Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab
The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis
The Use of Renin–Angiotensin–Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis
Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis
COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin a retrospective case series study
Safely Administering Potential QTc Prolonging Therapy Across a Large Healthcare System in the COVID-19 Era
Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis.
Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and Intensive Care Unit admission in patients with COVID-19 according to patients' oxygen requirements.
Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Vitamin D and survival in COVID-19 patients: A quasi-experimental study
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness
Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Efficacy and safety of tocilizumab in COVID-19 patients
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial
Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies
Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
Association of Anticoagulation Dose and Survival in Hospitalized COVID-19 Patients: A Retrospective Propensity Score Weighted Analysis
Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients
QTc prolongation among hydroxychloroquine sulfate-treated COVID-19 patients: An observational study
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis
Statin use is associated with lower disease severity in COVID‑19 infection
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Cohort study to evaluate effect of vitamin D, magnesium, and vitamin B12 in combination on severe outcome progression in older patients with coronavirus (COVID-19)
Efficacy of umifenovir in the treatment of mild and moderate COVID-19 patients
Preemptive interleukin‐6 blockade in patients with COVID‐19
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study.
Remdesivir for the Treatment of Covid-19 — Final Report
Convalescent plasma for patients with severe COVID-19
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review (Review)
Nitazoxanide against COVID-19 in three explorative scenarios
Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline
Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
Hydroxychloroquine in hospitalized COVID‐19 patients: Real world experience assessing mortality
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: na observational study
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience
Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study
Anticoagulation outcomes in hospitalized Covid‐19 patients: A systematic review and meta‐analysis of case‐control and cohort studies
Prophylactic anticoagulants for patients hospitalised with COVID-19
Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis
Convalescent plasma therapy in patients with COVID-19.
Is oseltamivir suitable for fighting against COVID-19: In silico assessment,in vitro and retrospective study
Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Ii Receptor Blockers and Prognosis of Hypertensive Patients Hospitalized With Covid-19
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
Hydroxychloroquine Use on Healthcare Workers Exposed to COVID-19 -A Pandemic Hospital Experience
Hydroxychloroquine is effective, and consistently so used early, for Covid-19: A systematic review
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19
Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels
Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses
Serum levels of Vitamin C and Vitamin D in a cohort of critically ill COVID-19 patients of a North American Community Hospital Intensive Care Unit in May 2020. A Pilot Study
COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients
Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis
Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus pneumonia: results of a randomized, open-labeled prospective study
Ivermectin treatment may improve the prognosis of patients with COVID-19
Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study
An open-label, randomized trial of the combination of IFN-k plus TFF2 with standard care in the treatment of patients with moderate COVID-19
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy
Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities
Ibuprofen use and clinical outcomes in COVID-19 patients
Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients
Assessing QT interval in COVID-19 patients: Safety of Hydroxychloroquine-azithromycin combination regimen
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
Treating Covid-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind, Randomized Controlled Trial in Hospitalized Patients
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study.
Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study
Vitamin D sufficiency, a serum 25hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Could Vitamins Help in the Fight Against COVID-19?
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
"Tocilizumab ameliorates the hypoxia in COVID-19 moderate patients withbilateral pulmonary lesions: a randomized, controlled, open-label, multicenter trial"
Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
Convalescent Plasma for the Treatment of Patients with Severe Coronavirus Disease 2019; a Preliminary Report
Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial
Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19
Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19)
Hydroxychloroquine and Interferons for the Prophylaxis and Early Treatment of Covid-19-Current Clinical Advances
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients.
A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Review)
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection
Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project)
Palliative Care Utilization Among Patients With COVID-19 in an Underserved Population: A Single-Center Retrospective Study
Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a singlecenter descriptive study
Analysis of the predictive factors for critical illness of COVID-19 during treatment - Relationship between serum zinc level and critical illness of COVID-19
Impact of Vitamin D Deﬁciency on COVID-19—A Prospective Analysis from the CovILD Registry
Vitamin D Deficiency and Outcome of COVID-19 Patients
Efficacy and safety of triazavirin therapy for coronavirus disease 2019: A pilot randomized controlled trial
Observational study on off-label use of tocilizumab in patients with severe COVID-19
Efficacy of Tocilizumab in COVID-19: A Systematic review and Meta-Analysis
A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients
Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran
Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region
The effect of antivirals on COVID-19: a systematic review
Terapia medicamentosa para infecções por coronavírus em humanos: revisão sistemática rápida.
Biological, Molecular and Pharmacological Characteristics of Chloroquine, Hydroxychloroquine, Convalescent Plasma, and Remdesivir for COVID-19 Pandemic: A Comparative Analysis
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients
Utilidad y seguridad de la automonitorizacion electrocardiográfica durante el tratamiento con hidroxicloroquina y azitromicina en pacientes con COVID-19
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in COVID‐19 patients
Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
Clinical characteristics of 132 healthcare workers cases with COVID-19: a retrospective study from a single center in Wuhan, China
Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Correlation between immunity from BCG and the morbidity and mortality of COVID-19
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes - Interim Analysis of 2 Randomized Clinical Trials
Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19
Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up
Outcome of COVID-19 patients with use of Tocilizumab: A single center experience
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
Analysis of the prophylactic effect of thymosin drugs on COVID‐19 for 435 medical staff: A hospital‐based retrospective study
Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature
Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review
Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study
COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
The Association of Renin-AngiotensinAldosterone System Inhibitors With Outcomes Among a Predominantly Ethnic Minority Patient Population Hospitalized With COVID-19: The Bronx Experience
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis
A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19
Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda
Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
Are the steroids a blanket solution for COVID‐19? a systematic review and meta‐analysis
Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
Agentes potencialmente terapéuticos contra el SARS-COV-2: revisión rápida de la evidencia
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
Chloroquine and Hydroxychloroquine in treatment of COVID-19 Disease
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-label Randomized Controlled Pilot Study
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Observational study of azithromycin in hospitalized patients with COVID-19
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study
The Impact of the “Low Molecular Weight Heparin” Administration on the Clinical Course of the COVID-19 Disease
Empiric therapeutic anticoagulation and mortality in critically ill patients with respiratory failure from SARS-CoV-2: A retrospective cohort study
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems
"Prolongation of QT interval due tohydroxychloroquine overdose used inCOVID-19 treatment"
Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection
Effect of oral L-Glutamine supplementation on Covid-19 treatment
Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
Dual-Histamine Receptor Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study
Tocilizumab use in COVID -19 associated pneumonia
Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-k plus TFF2 in patients with moderate COVID-19
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial,
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Effect of Calcifediol Treatment and best Available Therapy versus best Available Therapy on Intensive Care Unit Admission and Mortality Among Patients Hospitalized for COVID-19: A Pilot Randomized Clinical study
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
Safety and Effectiveness of Azithromycin in Patients with COVID-19: an open-label randomized trial
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: a rapid review
Directly Acting Antivirals for COVID-19: Where Do We Stand?
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis
Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials
The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Azithromycin: The First Broad-spectrum Therapeutic
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
Renin–angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study
Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19
Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis. view and Meta-Analysis
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
Is there any potential management against COVID-19? A systematic review and meta-analysis
Hydroxychloroquine is protective to the heart, not Harmful: A systematic review.
Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick—A Literature Review
"Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinicaltrial"
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU
Pattern of SARS-CoV-2 infection among dependant elderly residents living in retirement homes in Marseille, France, March-June 2020
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
Remdesivir is Effective for Moderately Severe Patients: A Re-Analysis of the First Double-Blind, Placebo-Controlled, Randomized Trial on Remdesivir for Treatment of Severe COVID-19 Patients Conducted in Wuhan City
Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients
Steroids in COVID-19: An overview
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19
The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Remdesivir and its antiviral activity against COVID-19: A systematic review
Fatal COVID-19 in an MS patient on natalizumab: A case report
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China
Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. Scientific brief
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Tocilizumab for severe COVID‐19 pneumonia: case series of 5 Australian patients
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
Impact of Famotidine Use on Clinical Outcomes of Hospitalized COVID-19 Patients
Baricitinib restrains the immune dysregulation in severe COVID-19 patients
Efficacy of various treatment modalities for nCOV‐2019: a systematic review and meta‐analysis
Recent Updates Published About Favipiravir in COVID-19
Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
Neumonía por COVID-19 y uso de tocilizumab
Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports
A case report of a pregnant woman infected with coronavirus disease 2019 pneumonia
Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
Severe arterial thromboembolism in patients with Covid- 19
Clinical Outcomes of Early Treatment With Doxycycline for 89 High-Risk COVID-19 Patients in Long-Term Care Facilities in New York
Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan
Lopinavir-ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia
"Corticosteroid prevents COVID-19 progressionwithin its therapeutic window: a multicenter, proof-of-concept, observational study"
Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients
Hydroxychloroquine for treatment of non-severe COVID-19 patients; systematic review and meta-analysis of controlled clinical trials
Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: a new challenge overcome?
The application of corticosteroids in COVID-19: A two-edged sword
Uncontrolled mass use of hydroxychloroquine
Short-term corticosteroid therapy for early exacerbation of COVID-19 pneumonia: a case report
Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial
Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis
Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
Agentes terapéuticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relación con la mortalidad
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID-19: Quantification and precautions for a busy clinician
Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
"Prolonged QT Interval in a PatientWith Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin"
Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
Análisis de la relación entre los inhibidores del sistema renina-angiotensina y la evolución de pacientes hospitalizados por infección respiratoria COVID-19
Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19
Efficacy of hydroxychloroquine and tocilizumab in patients with COVID-19: A single-center retrospective chart review
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary
Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19
Plasma exchange in critically ill COVID-19 patients
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
QTc prolongation during antiviral therapy in two COVID-19 patients
Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir
Impact of implementation of an individualised thromboprophylaxis protocol T in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study
Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results
SARS-CoV-2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in COVID-19 Patients
Vitamin D deficiency as a predictor of poor prognosis in patients with acute  respiratory failure due to COVID-19
Convalescent Plasma Therapy on Patients with Severe or Life-Threatening COVID-19: A Metadata Analysis
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials
Hydroxychloroquine in COVID-19: An updated systematic review with meta-analysis
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARSCoV-2 infection: a retrospective cohort study
Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients - Results from a real-life patient cohort
TREATMENT WITH HYDROXYCHLOROQUINE IN PATIENTS WITH COVID-19. EXPERIENCE OF A NEUROLOGY DEPARTMENT
Favipiravir y/o umifenovir en infección por COVID-19
Documento de Evaluación de Tecnologías Sanitarias – Informe de Respuesta Rápida: Ivermectina para COVID-19
Convalescent plasma a clutch at straws in COVID-19 management! A systematic review and meta-analysis
Potential new treatment strategies for COVID‐19: is there a role for bromhexine as add‐on therapy?
Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19
Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review
COVID-19 in Liver Transplant Patients: Report of 2 Cases and Review of the Literature
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
Corticoides sistémicos en COVID-19
Stem cell therapy for Covid‐19: possibilities and challenges
Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results
Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells
Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series
Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19
Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy
Corticosteroid therapy for patients with severe novel Coronavirus disease 2019
BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation
Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab
AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis
Searching for COVID-19 treatments: First, do no harm
The role of remdesivir in COVID -19 infection
Therapeutic response to corticosteroids in a critically ill patient with COVID-19
A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al
The effects of renin–angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective,single-center trial
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review
The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
COVID-19, asthma, and biologic therapies: What we need to know
Abordaje terapéutico del SARS-CoV-2 (COVID-19) mediante células mesenquimales de médula ósea alogénica expandidas. Conceptos a propósito de un primer caso en España
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID‑19
COVID-19 in pediatric patients: A case series
Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report
Clinical outcomes of COVID‑19 in Wuhan, China: a large cohort study
The characteristics and outcomes of 681 severe cases with COVID-19 in China.
Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report
Prolonged asymptomatic SARS-CoV-2 infection in a child receiving immunosuppressive therapy
Interferon-α2b spray inhalation did not shorten vírus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study
Corticosteroid, oseltamivir, and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019
Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time
Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin usage in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19
Tocilizumab for COVID-19: a real ‘miracle drug’?
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019: A Case Report
Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients
Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease  2019
A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients
Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study
Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis
Tratamiento farmacológico en tiempos de incertidumbre: uso de la hidroxicloroquina/cloroquina en el tratamiento de COVID-19
Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis
Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2
Ascorbate as Prophylaxis and Therapy for COVID-19—Update From Shanghai and U.S. Medical Institutions
Effect of favipiravir and an anti- inflammatory strategy for COVID-19
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
COVID-19 in a Patient With Rheumatoid Arthritis During Tocilizumab Treatment
Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab  and NIV in a Patient with COVID-19 Pneumonia/ARDS
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes
The Association of Interleukin-6 value, Interleukin inhibitors and Outcomes of Patients with COVID-19 in New York City
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Drug treatments for covid-19: living systematic review and network meta-analysis.
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data
Tratamento precoce para COVID-19 baseado em evidência científica.
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
Liver injury in remdesivir-treated COVID-19 patients
Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)
Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
Appropriate use of Tocilizumab in COVID-19 Infection
Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection
Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia
Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
Heparin-Induced Thrombocytopenia in COVID-19
Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study
Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU.
Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
COVID-19: Mechanisms of Vaccination and Immunity
Hydroxychloroquine and azithromycin combination could be lethal to covid-19 patients
Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection
ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids
Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia
Medication utilization in patients in New York hospitals during the COVID-19 pandemic
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
Tocilizumab for severe COVID-19: a systematic review and meta-analysis
Vacunas para SARS-CoV-2, diferentes estrategias de los desarrollos en curso
Remdesivir—Bringing Hope for COVID-19 Treatment
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine
Successful treatment of two Japanese ESRD cases with severe COVID‐19 pneumonia
COVID-19 and multiple sclerosis: a description of two cases on alemtuzumab
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure – a cautionary case series
High‐dose, short‐term corticosteroids for ARDS caused by COVID ‐19: a case series
Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C
An infant with coronavirus disease 2019 in China: A case report
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
Ribavirin Therapy For Severe COVID-19: A Retrospective Cohort Study
Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
BCG vaccination and COVID-19: Much ado about nothing?
Management of immunosuppression in kidney transplant recipients with COVID-19 pneumonia: A summary of 41 confirmed cases reported worldwide
Therapeutic Plasma Exchange: a potential management strategy for critically III COVID-19 patients. 2020
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
As the COVID-19 pandemic drags on, where have all the STEMIs gone?
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study
A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini- Review
Azithromycin in COVID‑19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19
The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report
High-dose chemotherapy in a patient with coronavirus disease (COVID-19)
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate COVID-19.
Use of remdesivir for patients with Covid-19: a review article
Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic
Hydroxychloroquine for COVID-19: What is Our Current State of Knowledge?
Anticoagulation, immortality, and observations of COVID-19
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria
Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection
Acute cor pulmonale in COVID-19-related ARDS: improvement with almitrine infusion
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab
"Effectiveness of Tocilizumab in a COVID-19 Patientwith Cytokine Release Syndrome"
SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor
Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation
Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: Three case reports
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome.
A possible benefit from therapeutic anticoagulation in COVID-19: the Dolo hospital experience in Veneto, Italy
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection
The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: the Padua province experience
Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib
Safety and Efficacy of Amiodarone in a Patient With COVID-19
Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis
Heparin‐induced Thrombocytopenia with Thrombosis in COVID‐19 Adult Respiratory Distress Syndrome
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series
Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19
Clinical characteristics and treatment of critically ill patients with COVID-19 in Hebei
COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: A tele-medicine experience
Use of tocilizumab in kidney transplant recipients with COVID-19
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with pcr positive SARS-Cov-2 infection including drug induced changes in the corrected qt interval (QTc) (2020)
Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study
Remdesivir for the Treatment of Covid-19 - Preliminary Report
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
Gastrointestinal Perforation After Treatment With Tocilizumab: An Unexpected Consequence of COVID-19 Pandemic
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report
Case Report: Clinical Treatment of the First Critical Patient With Coronavirus Disease (COVID-19) in Liaocheng, Shandong Province
QT Interval Evaluation Associated With Use of Hydroxychloroquine with Combined Use of Azithromycin Among Hospitalized Children Positive for COVID-19
Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin
Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
Vitamin D Sufficiency Reduced Risk for Morbidity and Mortality in COVID-19 Patients
COVID-19 in two infants in China
The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data
A critical evaluation of glucocorticoids in the management of severe COVID19
The cardiovascular effects of treatment with hydroxychloroquine and azithromycin
A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Effet bénéfique de l'association hydroxychloroquine/azithromycine dans le traitement des patients âgés atteints de la COVID-19: résultats d'une étude observationnelle
Mild COVID‐19 infection in an NMO patient treated with tocilizumab: a confrmation of anti‐IL‐6 protective role?
Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock
Cardiac Dysfunction and Shock in Pediatric Patients With COVID-19
COVID-19 in a patient with active tuberculosis: A rare case-report
Multiple Acute Ischemic Strokes in a COVID-19 Patient: a Case Report
Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: a single‐center cohort study
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial
Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial
Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19
Systematic Review and Meta-analysis of Effectiveness of Treatment Options Against SARS-CoV-2 infection
COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Corticosteroid administration for viral pneumonia: COVID-19 and beyond
Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy
Rethinking interleukin-6 blockade for treatment of COVID-19
Severe coronavirus infection in pregnancy: challenging cases report
Could anti‐hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID‐19 infection? Data from centers of southern Italy
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study
A retrospective review of memantine use and COVID-19-associated mortality from a national database
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
The Use of IV vitamin C for patients with COVID-19: a single center observational study
Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
Covid-19: A systemic disease treated with a wide-ranging approach: A case report
A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock
First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test
Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?
A Randomized, Open‐label, Controlled Clinical Trial of Azivudine Tablets in the Treatment of Mild and Common COVID‐19, A Pilot Study
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic
Pros and cons of corticosteroid therapy for COVID-19 patients
Coronavirus disease 2019 rash in a psoriatic patient treated with Secukinumab: is there a role for Interleukin 17?
Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases
Management of the first severe case of COVID-19 in the small islands of Maldives
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
Bacillus Calmette–Guérin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis
QT prolongation in adiverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an 1 Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)
Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19
Iloprost for COVID-19-related vasculopathy
Portal vein thrombosis in a patient with COVID-19
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab
Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysi
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living  systematic review
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
Role of vitamin D in preventing of COVID-19 infection, progression and severity
Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients
Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study
Coronavirus disease 2019 (COVID‑19) in a patient with ankylosing spondylitis treated with secukinumab: a case‑based review
Severe refractory COVID-19 patients responding to convalescent plasma; A case series
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia
Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management
Treating COVID-19 with Chloroquine
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
Primum non nocere _ Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Convalescent Plasma Therapy: Helpful Treatment of COVID-19 in a Kidney Transplant Recipient presenting with serve clinical manifestation and complex complications
Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia
Treatment of severe COVID-19 with tocilizumab mitigates cytokine storm and averts mechanical ventilation during acute respiratory distress: a case report and literature review
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide
Association between angiotensin blockade and COVID-19 severity in Hong Kong
Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy
Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives
Obstetric Management of COVID-19 in Pregnant Women
Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
Mortality and the use of antithrombotic therapies among nursing home residents with COVID ‐19
Successful use of tPA for thrombolysis in COVID related ARDS: a case series
Clinical characteristics of 16 patients with COVID-19 infection outside of Wuhan, China: a retrospective, single-center study
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)
An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can’t Get No) Satisfaction
Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk
Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.
A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin
Associations of clinical characteristics and treatment regimens with viral RNA shedding duration in patients with COVID-19
Serious adverse events associated with hydroxychloroquine amidst COVID-19 pandemic: case series and literature review
COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study
Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
Characteristics, treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: an epidemio-clinical study
Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy
Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
RAAS inhibitors do not increase the risk of COVID-19
Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)
Case reports study of the first five patients COVID-19 treated with remdesivir in France
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China
Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
Hydroxychloroquine as Prophylaxis or Treatment for COVID-19: What Does the Evidence Say?
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19
Massive Pulmonary Thromboembolism in Patients with COVID-19; Report of Three Cases
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas
Effects of Hydroxychloroquine Treatment on QT Interval
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
Use of Baricitinib in Patients with Moderate and Severe COVID-19
Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice
Severe COVID-19 Infection While on Long Standing Therapy with Hydroxychloroquine
Imatinib for COVID-19: A case report
Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with Pglycoprotein inhibitors
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Belatacept, kidney transplantation and COVID-19: successful management of the first reported case within the United Kingdom
Tratamiento y evolucion del sindrome de tormenta de citoquinas asociados a infeccion por SARS-CoV-2 en pacientes octogenários
Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
Role of corticosteroid in the management of COVID-19: A systemic review and a clinician’s perspective.
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Coronavirus disease-19 and rheumatological disorders: A narrative review
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient
Use of anakinra to prevent mechanical ventilation in severe COVID‐19: a case series
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatological and rheumatological patients already under treatment
Methylprednisolone added to tocilizumab reduces mortality in SARS‐CoV‐2 pneumonia: an observational study
Association of Hydroxychloroquine with QTc Interval in Patients
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial
Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19
Pneumococcal superinfection in COVID-19 patients: a series of 5 cases
Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 pneumonia
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Prior treatment with immunosuppressants among COVID‐19 inpatients at one hospital in Spain
Multisystem Inflammatory Syndrome in Children in New York State
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.
TB infection and BCG vaccination: are we protected from COVID-19?
Colchicin Treatment of Covid-19 Presenting With Cutaneous Rash and Myopericarditis
A case series of COVID‐19 patients with chronic hepatitis B virus infection
Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis
Ruxolitinib for Tocilizumab-Refractory Severe COVID-19 Infection
Amelioration of COVID-19 related cytokine storm syndrome: Parallels to chimeric antigen receptor-T cell cytokine release syndrome
A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment
Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery
A case of Covid-19 patient with acute limb ischemia and heparin resistance
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
Short-Term Dexamethasone in Sars-CoV-2 Patients
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab
Infusion of convalescent plasma is associated with clinical improvement in critically ill patients with COVID-19: a pilot study
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
SARS-CoV-2 infection and stem cells: Interaction and intervention.
Tocilizumab’s efficacy in COVID-19 patients is determined by the presence of cytokine storm.
Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment. Rheumatology.
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab
Clinical features and the treatment of children with COVID-19: A case series from Wenzhou, China
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Bradycardia in Patients With COVID-19: A Calm Before the Storm?
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19
Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion
BCG Vaccination in infancy does not protect against COVID‐19. Evidence from a natural experiment in Sweden
Investigational therapies for the treatment of COVID-19: updates from ongoing clinical trials.
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report.
Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019.
Vaccine development and therapeutic design for 2019‐ncov/SARS‐cov‐2: challenges and chances.
A Comprehensive Review on Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
Coagulopathy, thromboembolic complications and the use of heparin in COVID-19 Pneumonia,
Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes.
COVID-19 in patients with rheumatic diseases in northern Italy : a single-centre observational and case – control study.
Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital.
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
Antithrombotic Therapies in COVID-19 Disease: a Systematic Review.
Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020.
Vaccines and Therapies in Development for SARS-CoV-2 Infections
Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.
Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities.
Clinical characteristics, diagnosis, and treatment of COVID-19: A case report.
A child with a severe multi-system inflammatory syndrome following an asymptomatic COVID-19 infection: a novel management for a new disease?
COVID-19 in a young man with hypertension: A case study of missed opportunities in intensive progression.
Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019.
COVID-19 in a patient with severe asthma treated with Omalizumab.
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19
Use of amantadine in a patient with SARS‐Cov‐2.
Hydroxychloroquine treatment in COVID‐19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China.
Tocilizumab in patients with severe COVID-19: a single-center observational analysis.
"Clinical characteristics of 17 patients with COVID-19and systemic autoimmune diseases: aretrospective study."
Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
Baricitinib: A review of pharmacology, safety and emerging clinical experience in COVID-19.
Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov.
Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients.
Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19.
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
Subcutaneous administrationof interferon beta-1a for COVID-19: A noncontrolled prospective trial.
The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study.
Vaccination strategies to combat novel corona virus SARS-CoV-2.
Promising Antiviral Candidate Drug for the COVID-19 Pandemic: A Mini-Review of Remdesivir.
Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors.
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
Flight of the COVID-19 patient: experience with a Wuhan evacuee: a case report.
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
A Case Series of Patients Coinfected With Influenza and COVID-19.
Can steroids reverse the severe COVID-19 induced 'cytokine storm'?
COVID-19 in a patient with multiple sclerosis treated with natalizumab: may the blockade of integrins have a protective role?
Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study.
Association between renin-angiotensin system inhibitors and COVID-19 complications.
Eficacia de los pulsos de corticoides en pacientes con síndrome de liberación de citocinas inducido por infección por SARS-CoV-2.
Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection.
Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities.
Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns.
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.
COVID-19 in a severe eosinophilic asthmatic receiving benralizumab – a case study.
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review.
Efficacy and Safety of Antibiotic Agents in Children with COVID-19: A Rapid Review.
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.
The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
COVID-19 related coagulopathy: a distinct entity?
The Current Update of Vaccines for SARS-CoV-2.
A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids.
Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID -19.
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6.
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.
A study on clinical effect of Arbidol combined with adjuvant therapy on COVID‐19.
Efficacy of Almitrine in The Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19.
Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19
Tocilizumab in the treatment of a critical COVID-19 patient: a case report.
High‐dose, short‐term corticosteroids for ARDS caused by COVID‐19: a case series. Respirology Case Reports.
Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab.
Famotidine use and quantitative symptom tracking for COVID-19 in non- hospitalised patients: a case series.
Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report.
Tocilizumab administration in a refractory case of COVID-19.
Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review.
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
Anticardiolipin antibodies and COVID-19 - A Case Report from America.
Canakinumab in subgroup of patients with COVID-19.
Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019.
HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients.
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis.
USO DE IVERMECTINA PARA EL TRATAMIENTO DE PACIENTES ADULTOS CON COVID-19
Clinical characteristics and therapeutic procedure for a critical case of novel coronavirus pneumonia treated with glucocorticoids and non-invasive ventilator treatment.
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.
The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
Remdesivir and Tocilizumab: Mix or Match.
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China.
COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study.
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review.
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns.
Use of corticosteroids in asthma and COPD patients with or without COVID-19.
Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients.
Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature.
Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.
Covid-19 infection in psoriasis patients treated with cyclosporin.
Feasibility of Tocilizumab in ICU patients with COVID-19.
Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin.
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.
Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
Trials and tribulations: so many potential treatments, so few answers
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.
Interleukin-6 Blockade Treatment for COVID-19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia.
Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring
First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19.
Tocilizumab therapy in five solid and composite tissue transplant recipients with early ARDS due to SARS‐CoV‐2.
Successful use of methylprednisolone for treating severe COVID-19.
Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
The association between treatment with heparin and survival in patients with Covid-19.
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission—A Preliminary Report of a Retrospective Cohort Study.
Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome.
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.
Treatment of COVID-19 Patients with Convalescent Plasma
A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
Anakinra for severe forms of COVID-19 : a cohort study
COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, singleblind, randomized controlled trial
Ramipril in High Risk Patients with COVID-19
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome
Remdesivir para el tratamiento de infeccion por Covid-19. Informe de Revisión Rápida
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease‑19 (COVID‑19)
Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
Early outpatient treatment of symptomatic, high-risk Covid-19 patients that should be ramped-up immediately as key to the pandemic crisis
Can Zn Be a Critical Element in COVID-19 Treatment?
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes.
QT Interval Prolongation and Torsade de Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
Non-steroidal anti-inflammatory drugs in management of COVID-19; a systematic review on current evidence
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review
Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
Compassionate use of hzVSF-v13 in two patients with severe COVID-19
A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics
Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab
Early tocilizumab treatment could improve survival among COVID-19 patients
COVID‐SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature
Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review
A review on possible modes of actions of Chloroquine / Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic
Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus
Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury
Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review
Efficacy of therapeutic plasma exchange in severe COVID-19 patients
Apremilast as a potential treatment option for COVID-19: no symptoms of infection in a psoriatic patient
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
COVID-19 and systemic lupus erythematosus: a case series
Acetic acid disinfection as a potential adjunctive therapy for non-severe COVID-19
A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19
COVID-19 and Liver Transplantation: lessons learned from three reported cases
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
Arbidol/IFN-α2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases
Remdesivir: Review of pharmacology, pre-clinical data and emerging clinical experience for COVID-19
COVID-19 vaccines: knowing the unknown
Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019
COVID-19 and QT interval prolongation: more than just drug toxicity?
Heparin resistance in COVID-19 patients in the intensive care unit
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy [published online ahead of print
Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
Remdesivir for the Treatment of Covid-19 — Preliminary Report
QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review
Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
Hepatic complications of COVID‐19 and its treatment
Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19
The immunology of COVID-19: is immune modulation an option for treatment?
Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
Pharmaco-invasive Therapy for STEMI in a Patient with COVID-19: A Case Report
Extracorporeal Membrane Oxygenation as Treatment of Severe COVID-19 Infection: A Case Report
Baricitinib: a chance to treat COVID‐19?
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Early Outcomes with Utilization of Tissue Plasminogen Activator in COVID-19 Associated Respiratory Distress: A series of five cases
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
SARS2-CoV-2 and Stroke in a New York Healthcare System
Adjuvant corticosteroid therapy for critically ill patients with COVID-19
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence
Clinical Outcomes in COVID-19 Patients Treated with Tocilizumab: An Individual Patient Data Systematic Review
Hydroxychloroquine for COVID-19: A review and a debate based on available clinical trials/case studies
COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments
Thrombotic risk in COVID-19: a case series and case–control study
Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report
Pericarditis aguda secundaria a COVID-19
Successful Intravenous Immunoglobulin Treatment in Severe COVID-19 Pneumonia
Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA): A Case Series
The potential role of TNFα in 2019 novel coronavirus pneumonia
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care
The Effect of Potential Therapeutic Agents on QT Interval in Patients With COVID-19 Infection: The Importance of Close Monitoring and Correction of Electrolytes
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 Patients
Antivirals for COVID-19
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
Chloroquine and hydroxychloroquine during pregnancy: What do we know?
Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease
Cutaneous Sıde-Effects of the Potentıal Covıd-19 Drugs
Recovery from COVID-19 in two patients with coexisted HIV infection
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
COVID-19 Managed With Early Non-Invasive Ventilation and a Bundle Pharmacotherapy: A Case Report
Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report
Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir
‘‘Off-label’’ use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
Mesenchymal stem cell therapy in severe COVID-19: a retrospective study of short-term treatment efficacy and side effects
Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc
Is COVID-19 a New Hematologic Disease?
Advances in the Relationship Between Coronavirus Infection and Cardiovascular Diseases
A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?
Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report
COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
Early experience with remdesivir in SARS-CoV-2 pneumonia
Coronavirus disease 2019 in renal transplant recipients: report of two cases
Coronavirus Disease 2019 in Heart Transplant Recipients in Southeastern Michigan – Case Series
A Case of Coronavirus Disease 2019 Treated With Ciclesonide
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with Multiple Sclerosis during the early COVID-19 epidemic in Iran
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Complement activation in patientswith COVID-19: A novel therapeutictarget
The role of passive immunization in the age of SARS‑CoV‑2: an update
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
Appearance of Skin Rash in Pediatric Patients with COVID-19: Three Case Presentations
Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Nifedipine and Amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized for COVID-19
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19
Clinical characteristics and drug therapies in patients with the common‑type coronavirus disease 2019 in Hunan, China
Compassionate  remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19?
A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Combating COVID-19 with Mesenchymal Stem Cell therapy
A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine
Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19
Tolicizumab in severe COVID-19 pneumonia and concomitant cytokine release syndrome
Allogeneic cardiosphere‐derived cells (CAP‐1002) in critically ill COVID‐19 patients: compassionate‐use case series
Use of anakinra in severe COVID-19: a case report
Favorable anakinra responses in severe COVID-19 patients with secondary hemophagocytic lymphohistiocytosis
Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Interferon-α2b Treatment for COVID-19. 2020
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review
Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
Should azithromycin be used to treat COVID-19? A rapid review
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
Perspectives for repurposing drugs for the coronavirus disease 2019
The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury
2019 Novel Coronavirus Pneumonia With Onset of Dizziness: a Case Report
COVID‐19 in people living with human immunodefciency virus: a case series of 33 patients
Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report
COVID-19 vaccines: breaking record times to first-in-human trials
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
A global treatments for coronaviruses including COVID-19
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis
Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
A Hemodialysis Patient with Severe COVID-19 Pneumonia
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study
COVID-19 cases are less prevalent in countries where malaria is endemic, suggesting a role for anti-malarial drugs as prophylaxis
Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study
Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
A comparison analysis on Remdesivir, Favipiravir, Hydroxychloroquine, Chloroquine and Azithromycin in the treatment of corona virus disease 2019 (Covid-19) - A Review
Adverse Cardiac Events Related to Hydroxychloroquine Prophylaxis and Treatment of COVID-19
Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection.
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19
COVID-19: treating and managing severe cases
Early Experience of COVID-19 in Two Heart Transplant Recipients: Case Reports and Review of Treatment Options
Novel coronavirus 2019 (COVID-19): A case report and review of treatments. Medicine (Baltimore)
Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with Novel Coronavirus Disease (COVID-19) Treated with Hydroxychloroquine
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Triple combination of interferon beta-1b , lopinavir – ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial
Rapid review for the anti-coronavirus effect of remdesivir
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
A new era for the therapeutic management of the ongoing COVID-19 pandemic
Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight
Tocilizumab for the Treatment of Severe COVID-19
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061cases in Marseille, France
Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report
Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases
Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for Coronavirus Disease 2019 (COVID-19)
Cytokine storm intervention in the early stages of COVID-19 pneumonia
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19
Candidate drugs against SARS-CoV-2 and COVID-19
Quadruple therapy for asymptomatic COVID-19 infection patients
Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
Evidence for Use or Disuse of Renin–Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
Rethinking the role of hydroxychloroquine in the treatment of COVID-19
Efetividade e toxicidade da cloroquina e da hidroxicloroquina associada (ou não) à azitromicina para tratamento da COVID-19. O que sabemos até o momento?
Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
COVID-19: Immunology and treatment options
COVID-19: Therapeutics and Their Toxicities
Convalescent plasma: possible therapy for novel coronavirus disease 2019
A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Effective treatment of severe COVID-19 patients with tocilizumab
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Chloroquine-induced QTc prolongation in COVID-19 patients
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review
A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
Coronavirus Infections in Children Including COVID-19
The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis of patients in advanced disease state: A review
Treatment for emerging viruses: Convalescent plasma and COVID-19
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report
Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Will the antimalarial drug take over to combat COVID-19?
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19
Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
Darunavir does not prevent SARS-CoV-2 infection in HIV patients
Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report
SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs
Pharmacotherapy in COVID-19; A narrative review for emergency providers
COVID-19: An update on diagnostic and therapeutic approaches
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
Treatment of SARS-CoV-2: How far have we reached?
Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
Two distinct cases with COVID-19 in kidney transplant recipients
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Combating Devastating COVID -19 by Drug Repurposing
Pharmacologic perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
Update on treatment of COVID-19: ongoing studies between promising and disappointing results
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
Current status of potential therapeutic candidates for the COVID-19 crisis
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment
A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance
COVID-19: lambda interferon against viral load and hyperinflammation
Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thromobolytic drugs to treat COVID-19
Current pharmacological treatments for COVID-19: what’s next?
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options
Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
Incidence of Adverse Drug Reactions in COVID-19 patients in China: an active monitoring study by Hospital Pharmacovigilance System
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings
COVID-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency
A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Emerging Therapeutic Strategies for COVID-19 patients
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
Janus Kinase inhibitor baricitinib is not an ideal option for management of COVID-19
PAK1-blockers: Potential Therapeutics against COVID-19
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma
Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19)
Therapeutic strategies for critically ill patients with COVID-19
A short review on antibody therapy for COVID-19
Treatment options for COVID-19: The reality and challenges
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China
"Antiviral Therapy in Man-agement of COVID-19: a Systematic Review on Current Evidence"
Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Q1 Cell Transplantation and Cellular Therapy Patients in the United States
Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment
COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
Progress and Prospects on Vaccine Development against SARS-CoV-2
Clinical Implications of SARS-CoV-2 Interaction with Renin Angiotensin System
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
Perspectives: Potential Therapeutic Options for SARS-CoV-2 Patients Based on Feline Infectious Peritonitis Strategies: Central Nervous System Invasion and Drug Coverage
Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19
Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19
Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
Antiviral treatment of COVID-19
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient
The epidemiology and clinical information about COVID-19
COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies
Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection
Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment
Hydroxychloroquine and covid-19
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine.
Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis
Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Remdesivir, la esperanza antiviral frente al SARS-CoV-2
Mesenchymal stem cells and management of COVID-19 pneumonia
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study
Cytokine Storm in COVID-19 and Treatment
Can Hepatitis A Vaccine Provide Protection Against COVID-19?
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)
Arbidol Monotherapy is Superior to Lopinavir/ritonavir in Treating COVID-19
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
Traditional Chinese medicine for treatment of coronavirus disease 2019: a review.
Drug repositioning an alternative for the treatment of coronavirus COVID-19
Delayed Initiation of Remdesivir in a COVID-19 Positive Patient.
The possible of immunotherapy for COVID-19: A systematic review
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
COVID-19: A promising cure for the global panic
Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats
Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society
Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19)
Síntesis rápida: Tratamiento farmacológico de la infección por COVID-19 en adultos (Pharmacological interventions for adults with COVID-19 infection: Rapid Synthesis – Up to date)
Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?
Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report
Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19
Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020)
Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
Clinical Outcomes of Hydroxychloroquine in Hospitalized Patients with COVID-19: A Quasi-Randomized Comparative Study
Tratamento precoce de 1061 pacientes COVID-19 com hidroxicloroquina e azitromicina, Marselha, França
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
Metronidazole; a Potential Novel Addition to the COVID-19 Regimen
Tocilizumab treatment in COVID-19: a single center experience
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Heavner MS. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Current Drugs with Potential for Treatment of COVID-19: A Literature Review
Estudo Preliminar de Sintomas e Medicamentos Prevalentes do “Gênio Pandêmico” da Pandemia de Covid-19 no Brasil
The potential of low molecular weight heparin to mitigatie cytokine storm in severe covid-19 patients: a retrospective clinical study
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Infuenza and obesity: its odd relationship and the lessons for COVID‑19 pandemic
Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Potential therapeutic agents against COVID-19: What we know so far
Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection
Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, Chin